• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞移植中支气管内 Epstein-Barr 病毒相关移植后淋巴组织增生性疾病

Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation.

作者信息

Feuillet S, Meignin V, Brière J, Brice P, Rocha V, Socié G, Tazi A, Bergeron A

机构信息

Université Denis Diderot-Paris 7, Assistance Publique-Hôpitaux de Paris, Service de Pneumologie, Hôpital Saint-Louis, Paris, France.

出版信息

Clin Med Case Rep. 2009 Feb 3;2:11-5. doi: 10.4137/ccrep.s2084. eCollection 2009.

DOI:10.4137/ccrep.s2084
PMID:24179366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3785368/
Abstract

The Epstein-Barr virus (EBV) associated Post-Transplant Lymphoproliferative Disorders (PTLD) are increasingly recognized as a fatal complication of hematological stem cell transplantation (HSCT). Thoracic involvement, that may be isolated or part of a disseminated disease, usually encompasses pulmonary nodules or masses and mediastinal lymph node enlargement. The current case study presents 2 patients who underwent HSCT, one allogenic and the other autologous, who developed an exceptional endobronchial EBV related PTLD. The first patient had a fleshy white endobronchial mass resulting in a right upper lobe atelectasis and the second had an extensive necrotising mucosa from trachea to both basal bronchi without any significant change of lung parenchyma on the CT scan. In both cases, the diagnosis was made by bronchial biopsies. Physicians should be aware of an endobronchial pattern of EBV associated PTLD after HSCT to permit quick diagnosis and therapeutic intervention.

摘要

爱泼斯坦-巴尔病毒(EBV)相关的移植后淋巴细胞增殖性疾病(PTLD)日益被认为是血液干细胞移植(HSCT)的一种致命并发症。胸部受累可能是孤立的,也可能是播散性疾病的一部分,通常包括肺结节或肿块以及纵隔淋巴结肿大。本病例研究介绍了2例接受HSCT的患者,1例为同种异体移植,另1例为自体移植,他们均发生了罕见的支气管内EBV相关PTLD。首例患者有一个肉质白色支气管内肿物,导致右上叶肺不张,第二例患者从气管到双侧基底支气管有广泛的坏死性黏膜,CT扫描显示肺实质无明显变化。在这两例中,均通过支气管活检做出诊断。医生应意识到HSCT后EBV相关PTLD的支气管内表现形式,以便能够快速诊断并进行治疗干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/3785368/3278c1ef1af0/ccrep-2-2009-011f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/3785368/9a75465a6a92/ccrep-2-2009-011f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/3785368/3278c1ef1af0/ccrep-2-2009-011f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/3785368/9a75465a6a92/ccrep-2-2009-011f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/3785368/3278c1ef1af0/ccrep-2-2009-011f2.jpg

相似文献

1
Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation.造血干细胞移植中支气管内 Epstein-Barr 病毒相关移植后淋巴组织增生性疾病
Clin Med Case Rep. 2009 Feb 3;2:11-5. doi: 10.4137/ccrep.s2084. eCollection 2009.
2
Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.EB 病毒阳性淋巴组织增生性疾病在急性髓系白血病患者中表现为肺部疾病:病例报告。
J Med Case Rep. 2021 Mar 28;15(1):170. doi: 10.1186/s13256-021-02744-2.
3
Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植中与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增殖性疾病预防策略
Rev Med Virol. 2020 Jul;30(4):e2108. doi: 10.1002/rmv.2108. Epub 2020 Apr 17.
4
Orbital Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a 13-year-old girl with cord blood transplantation.13 岁女孩行脐血移植后发生眼眶 EBV 相关移植后淋巴组织增生性疾病。
Transpl Infect Dis. 2021 Jun;23(3):e13536. doi: 10.1111/tid.13536. Epub 2020 Dec 18.
5
T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein-Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma.自体造血干细胞移植治疗 EBV 阳性弥漫性大 B 细胞淋巴瘤后肺部伴有肉芽肿病变的 T 细胞淋巴瘤:B 细胞和 T 细胞淋巴瘤异时性发生的独特罕见病例。
Diagn Pathol. 2020 Oct 9;15(1):125. doi: 10.1186/s13000-020-01038-3.
6
Epstein-Barr virus-associated posttransplant lymphoproliferative disorder involving the central nervous system following autologous hematopoietic stem cell transplantation for neuroblastoma.在神经母细胞瘤自体造血干细胞移植后发生的与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病累及中枢神经系统。
Springerplus. 2014 Oct 6;3:582. doi: 10.1186/2193-1801-3-582. eCollection 2014.
7
Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.儿童异基因造血干细胞移植中与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病前瞻性预防方案:病毒学监测及一线治疗
Transpl Infect Dis. 2016 Feb;18(1):44-54. doi: 10.1111/tid.12485. Epub 2016 Jan 30.
8
Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.造血干细胞受体中爱泼斯坦-巴尔病毒相关移植后淋巴细胞增生性疾病的治疗结果:对报告病例的综合回顾
Transpl Infect Dis. 2009 Oct;11(5):383-92. doi: 10.1111/j.1399-3062.2009.00411.x. Epub 2009 Jun 23.
9
Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation.接受造血干细胞移植后抗 CD20 治疗的患者中 EBV 相关移植后淋巴组织增殖性疾病。
Biol Blood Marrow Transplant. 2019 Dec;25(12):2490-2500. doi: 10.1016/j.bbmt.2019.08.006. Epub 2019 Aug 14.
10
Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation.造血干细胞移植后移植后淋巴组织增生性疾病患者的爱泼斯坦-巴尔病毒相关肺炎
Transpl Infect Dis. 2010 Aug 1;12(4):284-91. doi: 10.1111/j.1399-3062.2010.00502.x. Epub 2010 Mar 23.

引用本文的文献

1
A Rare Case of Post-Transplant Lymphoproliferative Disorder Presenting as Hodgkin Lymphoma After Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review.自体造血干细胞移植后表现为霍奇金淋巴瘤的移植后淋巴细胞增生性疾病1例罕见病例报告及文献复习
Onco Targets Ther. 2025 Jan 14;18:27-33. doi: 10.2147/OTT.S490591. eCollection 2025.
2
Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies.血液系统恶性肿瘤患者体外膜肺氧合支持的临床结局
Korean J Intern Med. 2015 Jul;30(4):478-88. doi: 10.3904/kjim.2015.30.4.478. Epub 2015 Jun 29.

本文引用的文献

1
Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute.异基因造血干细胞移植后合并肺部受累的移植后淋巴细胞增殖性疾病预后不良:单中心13年经验
Bone Marrow Transplant. 2009 Feb;43(4):315-21. doi: 10.1038/bmt.2008.325. Epub 2008 Oct 6.
2
EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT.异基因造血干细胞移植后的EB病毒激活及移植后淋巴增殖性疾病
Bone Marrow Transplant. 2008 Aug;42(3):181-6. doi: 10.1038/bmt.2008.150. Epub 2008 Jun 2.
3
Epstein-Barr virus-associated post-transplant lymphoproliferative disorders presented as interstitial pneumonia; successful recovery with rituximab.
Haematologica. 2007 Apr;92(4):e49-52. doi: 10.3324/haematol.11142.
4
Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.单药利妥昔单抗治疗后对难治性和复发性移植后淋巴细胞增殖性疾病(PTLD)进行挽救性化疗。
Transplantation. 2007 Apr 15;83(7):912-8. doi: 10.1097/01.tp.0000258647.50947.78.
5
Treatment of PTLD with rituximab or chemotherapy.用利妥昔单抗或化疗治疗移植后淋巴增殖性疾病。
Am J Transplant. 2006 Mar;6(3):569-76. doi: 10.1111/j.1600-6143.2005.01211.x.
6
Post-transplant lymphoproliferative disorder.移植后淋巴细胞增生性疾病
Clin Chest Med. 2005 Dec;26(4):631-45, vii. doi: 10.1016/j.ccm.2005.06.014.
7
Epstein-Barr virus: the impact of scientific advances on clinical practice.爱泼斯坦-巴尔病毒:科学进展对临床实践的影响。
Blood. 2006 Feb 1;107(3):862-9. doi: 10.1182/blood-2005-07-2702. Epub 2005 Oct 18.
8
Thoracic presentations of posttransplant lymphoproliferative disorders.移植后淋巴增殖性疾病的胸部表现
Chest. 2004 Dec;126(6):2013-20. doi: 10.1378/chest.126.6.2013.
9
Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.用于移植后淋巴细胞增生性疾病过继性免疫治疗的爱泼斯坦-巴尔病毒特异性细胞毒性T淋巴细胞
Blood Rev. 2004 Sep;18(3):193-209. doi: 10.1016/j.blre.2003.12.002.
10
Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.移植后淋巴细胞增生性疾病:肺移植受者的发病率、表现及对治疗的反应
Chest. 2003 Oct;124(4):1242-9. doi: 10.1378/chest.124.4.1242.